Nicholas Lydon's Net Worth

Nicholas Lydon's net worth is estimated to be at least $10,941,588.08 as of 05/30/2024. CoreStreet's estimation of Nicholas Lydon's net worth is based on their sale of stock and current holding of stock.

Nicholas Lydon is Director at Blueprint Medicines Corp. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 500 units of BPMC stock on 09/17/2020. Their biggest sale was on 04/16/2018 when they sold 33,000 units of AnaptysBio Inc stock for $2,867,040.00. They typically trade 2 times per year.

Total value of insider buys:
  • $249,990.00
Total value of insider sells:
  • $10,691,598.08
Most recent insider trade:
  • Sept. 17, 2020

Nicholas Lydon's Insider Trading History

Blueprint Medicines CorpTitleAmountPriceTypeTotal Value
Sept. 17, 2020
Director500$80.00Sell$40,000.00
July 6, 2020
Director26,007$80.45Sell$2,092,263.15
July 2, 2020
Director4,125$80.16Sell$330,660.00
June 22, 2020
Director13,017$80.29Sell$1,045,134.93
June 12, 2019
Director25,000$84.77Sell$2,119,250.00
Feb. 28, 2018
Director25,000$87.89Sell$2,197,250.00
AnaptysBio IncTitleAmountPriceTypeTotal Value
April 16, 2018
Director33,000$86.88Sell$2,867,040.00
Jan. 31, 2017
Director16,666$15.00Buy$249,990.00